Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect Of The Bisphosphonate, Zoledronic Acid, On Bone Density In Liver Transplant Patients - A Prospective, Randomised, Controlled Clinical Trial

NCT00114556 is registered in ClinicalTrials.gov with Royal Prince Alfred Hospital, Sydney, Australia as lead sponsor.

NCT NCT00114556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00114556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect Of The Bisphosphonate, Zoledronic Acid, On Bone Density In Liver Transplant Patients - A Prospective, Randomised, Controlled Clinical Trial
Lead sponsor
Royal Prince Alfred Hospital, Sydney, Australia
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2000
Completion date
August 31, 2004
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fractures, liver transplantation, osteoporosis